Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease via integrin α8-mediated activation of RhoA signaling pathway.

MLA

Cai, Qingxian, et al. “Epigenetic Silencing of MicroRNA-125b-5p Promotes Liver Fibrosis in Nonalcoholic Fatty Liver Disease via Integrin Α8-Mediated Activation of RhoA Signaling Pathway.” Metabolism: Clinical & Experimental, vol. 104, Mar. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.metabol.2020.154140.

APA

Cai, Q., Chen, F., Xu, F., Wang, K., Zhang, K., Li, G., Chen, J., Deng, H., & He, Q. (2020). Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease via integrin α8-mediated activation of RhoA signaling pathway. Metabolism: Clinical & Experimental, 104, N.PAG. https://doi.org/10.1016/j.metabol.2020.154140

Chicago

Cai, Qingxian, Fengjuan Chen, Fen Xu, Ke Wang, Ka Zhang, Guojun Li, Jun Chen, Hong Deng, and Qing He. 2020. “Epigenetic Silencing of MicroRNA-125b-5p Promotes Liver Fibrosis in Nonalcoholic Fatty Liver Disease via Integrin Α8-Mediated Activation of RhoA Signaling Pathway.” Metabolism: Clinical & Experimental 104 (March): N.PAG. doi:10.1016/j.metabol.2020.154140.